References
<A NAME="RD14102ST-1A">1a</A>
Lee YC.
Lee RT.
Acc.
Chem. Res.
1995,
28:
321
<A NAME="RD14102ST-1B">1b</A>
Sharon N.
Lis H.
Essays Biochem.
1995,
30:
59
<A NAME="RD14102ST-1C">1c</A>
Lasky LA.
Annu. Rev. Biochem.
1995,
64:
113
<A NAME="RD14102ST-1D">1d</A>
Weis WI.
Drickamer K.
Annu.
Rev. Biochem.
1996,
65:
441
<A NAME="RD14102ST-1E">1e</A>
Sears P.
Wong C.-H.
Chem. Commun.
1998,
1161
<A NAME="RD14102ST-1F">1f</A>
Essential of Glycobiology
Varki A.
Cummings R.
Esko J.
Freeze H.
Hart G.
Marth J.
Cold Spring
Harbor Laboratory Press;
Cold Spring Harbor, New York:
1999.
<A NAME="RD14102ST-2A">2a</A>
Quiocho FA.
Pure Appl. Chem.
1989,
61:
1293
<A NAME="RD14102ST-2B">2b</A>
Glaudemans CPJ.
Chem. Rev.
1991,
91:
25
<A NAME="RD14102ST-2C">2c</A>
Toone EJ.
Curr. Opin. Struct. Biol.
1994,
4:
719
<A NAME="RD14102ST-2D">2d</A>
Lemieux RU.
Acc. Chem. Res.
1996,
29:
373
<A NAME="RD14102ST-3A">3a</A>
Connolly DT.
Townsend RR.
Kawaguchi K.
Bell WR.
Lee YC.
J.
Biol. Chem.
1982,
257:
939
<A NAME="RD14102ST-3B">3b</A>
Lee YC.
Townsend RR.
Hardy MR.
Lönngren J.
Arnap J.
Haraldsson M.
Lönn H.
J. Biol. Chem.
1983,
258:
199
<A NAME="RD14102ST-3C">3c</A>
Lee RT.
Lee YC.
Biochem. Biophys. Res.
Commun.
1988,
155:
1444
<A NAME="RD14102ST-4">4</A> For a classification of various types
of glycoside clusters and relevant references, see:
Dondoni A.
Kleban M.
Hu X.
Marra A.
Banks HD.
J.
Org. Chem.
2002,
67:
4722
<A NAME="RD14102ST-5A">5a</A>
Mammen M.
Choi S.-K.
Whitesides GM.
Angew. Chem.,
Int. Ed.
1998,
37:
2754
<A NAME="RD14102ST-5B">5b</A>
Davis BG.
Jones JB.
Synlett
1999,
1495
<A NAME="RD14102ST-5C">5c</A>
Davis AP.
Wareham RS.
Angew. Chem.,
Int. Ed.
1999,
38:
2978
<A NAME="RD14102ST-5D">5d</A>
Kitov PI.
Sadowska JM.
Mulvey G.
Armstrong GD.
Ling H.
Pannu NS.
Read RJ.
Bundle DR.
Nature
(London)
2000,
403:
669
<A NAME="RD14102ST-5E">5e</A>
Fan E.
Zhang Z.
Minke WE.
Hou Z.
Verlinde CLMJ.
Hol WGJ.
J.
Am. Chem. Soc.
2000,
122:
2663
<A NAME="RD14102ST-6A">6a</A>
Liu B.
Roy R.
J.
Chem. Soc., Perkin Trans. 1
2001,
773
<A NAME="RD14102ST-6B">6b</A>
Liu B.
Roy R.
Tetrahedron
2001,
57:
6909
<A NAME="RD14102ST-6C">6c</A>
Liu B.
Roy R.
Chem. Commun.
2002,
594
<A NAME="RD14102ST-7">7</A>
Gan Z.
Roy R.
Tetrahedron Lett.
2000,
41:
1155
<A NAME="RD14102ST-8A">8a</A> The
C-glucoside 1 was synthesized according
to the experimental procedure reported in the literature:
Lowary T.
Meldal M.
Helmboldt A.
Vasella A.
Bock K.
J.
Org. Chem.
1998,
63:
9657
<A NAME="RD14102ST-8B">8b</A>
Mp 66-67 °C(pentane), [α]
D²0 = +17.3
(c 2.0, CHCl3); lit.
[9]
mp 58 °C, [α]D
20 = +17.4
(c 1.6, CHCl3)
<A NAME="RD14102ST-9">9</A>
Alzeer J.
Vasella A.
Helv. Chim. Acta
1995,
78:
177
<A NAME="RD14102ST-10">10</A>
Compound 3:
mp 178-180 °C (AcOEt-cyclohexane); [α]D
20 = +7.4
(c 1.0, CHCl3); 1H
NMR selected data (C6D6): δ = 3.96
(dd, 1 H, J
1,3 = 2.2
Hz, J
3,4 = 9.7 Hz,
H-3), 3.76 (dd, 1 H, J
4,5 = 8.8
Hz, J
5,6 = 9.7 Hz,
H-5), 1.99 (d, 1 H, H-1).
<A NAME="RD14102ST-11A">11a</A>
Sonogashira K.
Tohda Y.
Hagihara N.
Tetrahedron Lett.
1975,
50:
4467
<A NAME="RD14102ST-11B">11b</A>
Dieck HA.
Heck FR.
J. Orgmet.
Chem.
1975,
93:
259
<A NAME="RD14102ST-11C">11c</A>
Cassar L.
J.
Orgmet. Chem.
1975,
93:
253
For reviews, see:
<A NAME="RD14102ST-12A">12a</A>
Sonogashira K. In
Comprehensive Organic
Synthesis
Vol. 3:
Trost BM.
Fleming I.
Pergamon
Press;
New York:
1991.
p.521
<A NAME="RD14102ST-12B">12b</A>
Rossi R.
Carpita A.
Bellina F.
Org.
Prep. Proced. Int.
1995,
27:
129
<A NAME="RD14102ST-12C">12c</A>
Tsuji J.
Palladium Reagents and Catalysts
Wiley & Sons;
Chichester:
1995.
p.168
<A NAME="RD14102ST-12D">12d</A>
Brandsma L.
Vasilevsky SF.
Verkruijsse HD.
Application
of Transition Metal Catalysts in Organic Synthesis
Springer;
Berlin:
1998.
p.179
<A NAME="RD14102ST-13">13</A>
Compound 5:
mp 150-151 °C(cyclohexane); [α]D
20 =-54.6 (c 1.0, CHCl3); 1H
NMR (CDCl3): δ 7.40-7.25 and 7.17-7.12
(2 m, 44 H, Ar), 5.05 and 4.87 (2 d, 4 H, J = 10.7
Hz, PhCH
2), 4.96 and 4.87
(2 d, 4 H, J = 11.1 Hz, PhCH
2), 4.85 and 4.55 (2 d, 4
H, J = 11.0 Hz, PhCH
2), 4.66 and 4.57 (2 d, 4
H, J = 12.4 Hz, PhCH
2), 4.33-4.27 (m,
2 H, 2 H-3), 3.81-3.66 (m, 10 H), 3.55-3.49 (m,
2 H); MALDI-TOF MS: 1196.1 (M + Na + 2
H), 1212.4 (M + K + 2 H). Compound 6:
mp 180-181 °C (AcOEt-MeOH); [α]20
D = -33.1
(c 0.8, CH3OH); 1H
NMR (D2O): δ 7.12 (s, 4 H, Ar), 3.77 (dd, 2
H, J
7,8a = 0.8 Hz, J
8a,8b = 12.2 Hz,
2 H-8a), 3.58-3.51 (m, 2 H, 2 H-8b), 3.28-3.16
(m, 6 H), 3.11-3.02 (m, 4 H), 2.77-2.52, 2.03-1.90,
and 1.65-1.52 (3 m, 8 H, 4 H-1, 4 H-2). Compound 7: mp 279-280 °C (CHCl3-Et2O); [α]D
20 =-58.5 (c 1.1, CHCl3); 1H
NMR (C6D6): δ 7.12 (s, 4 H, Ar),
5.50 (dd, 2 H, J
3,4 = 9.9
Hz, J
4,5 = 9.1 Hz,
2 H-4), 5.32 (dd, 2 H, J
5,6 = 9.3
Hz, 2 H-5), 5.24 (dd, 2 H, J
6,7 = 9.6
Hz, 2 H-6), 4.22 (dd, 1 H, J
7,8a = 4.6
Hz, J
8a,8b = 12.6
Hz, 2 H-8a), 4.07 (d, 2 H, 2 H-3), 4.02 (dd, 2 H, J
7,8b = 2.0
Hz, 2 H-8b), 3.13 (ddd, 2 H, 2 H-7), 1.69, 1.68, 1.66, and 1.64
(4 s, 24 H, 8 Ac); MALDI-TOF MS: 810.2 (M + Na),
826.8 (M + K). Compound 8: mp 254-255 °C
(MeOH-AcOEt); [α]D
20 = 0
(c 0.3, CH3OH); [α]43620 = -9.0
(c 0.3, CH3OH); 1H
NMR (CD3OD): δ 7.45 (s, 4 H, Ar), 4.21-4.15
(m, 2 H, 2 H-3), 3.90 (dd, 2 H, J
7,8a = 0.8 Hz, J
8a,8b = 12.0 Hz,
2 H-8a), 3.72-3.64 (m, 2 H, 2 H-8b), 3.43-3.27 (m, 8 H).
<A NAME="RD14102ST-14">14</A>
Godt A.
Franzen C.
Veit S.
Enkelmann V.
Pannier M.
Jeschke G.
J. Org. Chem.
2000,
65:
7575
<A NAME="RD14102ST-15">15</A>
Compound 10:
mp 133-134 °C (AcOEt-MeOH); [α]D
20 =
-48.5
(c 1.2, CHCl3); 1H
NMR (CDCl3): δ 7.43 (s, 3 H, Ar), 7.39-7.22
and 7.18-7.13 (2 m, 60 H, 12 Ph), 4.96 and 4.82 (2 d, 6
H, J = 10.7 Hz, PhCH
2), 4.95 and 4.86 (2 d, 6
H, J = 11.0 Hz, PhCH
2), 4.85 and 4.56 (2 d, 6
H, J = 11.0 Hz, PhCH
2), 4.65 and 4.56 (2 d, 6
H, J = 12.3 Hz, PhCH
2), 4.30-4.24 (m,
3 H, 3 H-3), 3.81-3.66 (m, 15 H), 3.54-3.48 (m,
3 H); MALDI-TOF MS: 1742.0 (M + Na), 1758.4 (M + K). Compound 11: mp 234-236 °C (AcOEt); [α]D
20 = -58.4
(c 0.9, CHCl3); 1H
NMR (C6D6): δ 7.33 (s, 3 H, Ar),
5.46 (dd, 3 H, J
3,4 = 9.8
Hz, J
4,5 = 9.2 Hz,
3 H-4), 5.32 (dd, 3 H, J
5,6 = 9.1
Hz, 3 H-5), 5.24 (dd, 3 H, J
6,7 = 9.6
Hz, 3 H-6), 4.23 (dd, 3 H, J
7,8a = 4.5
Hz, J
8a,8b = 12.5
Hz, 3 H-8a), 4.03 (dd, 3 H, J
7,8b = 2.0
Hz, 3 H-8b), 4.00 (d, 3 H, 3 H-3), 3.14 (ddd, 3 H, 3 H-7), 1.79,
1.68, 1.66, and 1.65 (4 s, 36 H, 12 Ac); MALDI-TOF MS:
1164.3 (M + Na), 1180.7 (M + K). Compound 12: mp 178-180 °C, dec.
(MeOH); [α]D
20 = +5.5 (c 0.2, CH3OH); 1H
NMR (D2O): δ 7.55 (s, 3 H, Ar), 4.24-4.17
(m, 3 H, 3 H-3), 3.80 (dd, 3 H, J
7,8a = 0.9
Hz, J
8a,8b = 12.5
Hz, 3 H-8a), 3.60 (dd, 3 H, J
7,8b = 5.0
Hz, 3 H-8b), 3.45-3.28 (m, 12 H). Compound 13: [α]D
20 = -39.6
(c 0.8, CH3OH); 1H
NMR (D2O): δ 6.93 (s, 3 H, Ar), 3.80 (dd, 3
H, J
7,8a = 0.9 Hz, J
8a,8b = 12.2 Hz,
3 H-8a), 3.58 (dd, 3 H, J
7,8b = 5.0
Hz, 3 H-8b), 3.28-3.16 (m, 9 H), 3.13-2.98 (m,
6 H), 2.77-2.54, 2.05-1.91, and 1.69-1.55
(3 m, 12 H, 6 H-1, 6 H-2). Compound 14:
mp 116 °C, softening 86 °C(cyclohexane); [α]D
20 = -10.8
(c 0.5, CHCl3); 1H
NMR (CDCl3) selected data: δ 7.41 (s, 3 H, Ar),
7.35-7.15 (m, 105 H, 21 Ph), 4.23-4.18 (m, 3 H,
3 H-3), 3.71-3.59 (m, 18 H), 3.42-3.18 (m, 15
H), 2.22-2.15 and 1.55-1.46 (2 m, 12 H, 6 H-8,
6 H-9); MALDI-TOF MS: 3035.7 (M + Na + 3
H), 3051.7 (M + K + 3 H). Compound 15Ac:
mp 245-246 °C (EtOAc); [α]D
20 =-13.0
(c 0.4, CHCl3); 1H
NMR (CDCl3): δ 6.79 (s, 3 H, Ar), 5.20 (dd,
3 H, J
11,12 = J
12,13 = 9.4 Hz,
3 H-12), 5.14 (dd, 3 H, J
4,5 = J
5,6 = 9.3 Hz, 3
H-5), 5.06 (dd, 3 H, J
13,14 = 10.0
Hz, 3 H-13), 4.91 (dd, 3 H, J
10,11 = 9.9
Hz, 3 H-11), 4.86 (dd, 3 H, J
3,4 = 9.9
Hz, 3 H-4), 4.86 (dd, 3 H, J
6,7 = 9.9
Hz, 3 H-6), 4.29 (dd, 3 H, J
14,15a = 5.0, J
15a,15b = 12.2 Hz, 3
H-15a), 4.11 (dd, 3 H, J
14,15b = 2.2
Hz, 3 H-15b), 3.67 (ddd, 3 H, 3 H-14), 3.46-3.33 (m, 9 H, 3 H-3,
3 H-7, 3 H-10), 2.87-2.76, 2.51-2.40, 1.94-1.85,
1.77-1.68, and 1.52-1.39 (5 m, 24 H), 2.12, 2.08,
2.06, 2.02, 2.01, and 1.98 (6 s, 63 H, 21 Ac).
<A NAME="RD14102ST-16">16</A>
Dondoni A.
Giovannini PP.
Marra A.
J.
Chem. Soc., Perkin Trans. 1
2001,
2380
<A NAME="RD14102ST-17">17</A>
Mattern DL.
J.
Org. Chem.
1984,
49:
3051
<A NAME="RD14102ST-18">18</A>
A solution of 2 (157
mg, 0.44 mmol) and 16 (58 mg, 0.10 mmol)
in anhydrous DMF (1.6 mL) and Et3N (1.6 mL) was degassed
by bubbling argon at r.t. for 20 min. To the solution was added
commercially available Pd(PPh3)4 (23 mg, 0.02 mmol)
and the suspension was stirred at 60 °C in an argon atmosphere.
After an additional 24 h at 60 °C the red-brown solution
was concentrated, then diluted with CH2Cl2 (50 mL),
washed with 1 M phosphate buffer at pH = 7 (20 mL), dried
(Na2SO4), and concentrated. The residue was
eluted from a column of silica gel with EtOAc-cyclohexane
(from 2:1 to 3:1) to give 17 (94 mg) slightly
contaminated by uncharacterized byproducts. Trituration of this
material with Et2O (ca. 2 mL) afforded pure 17 (74 mg, 49%) as a white solid;
mp 119-120 °C (MeOH); [α]D
20 = -70.0
(c 1.0, CHCl3); 1H
NMR (C6D6): δ 7.30 (s, 2 H, Ar),
5.58-5.51 (m, 4 H, 4 H-4), 5.42-5.31 (m, 8 H,
4 H-5, 4 H-6), 4.31 (d, 4 H, J
3,4 = 9.8
Hz, 4 H-3), 4.30 (dd, 4 H, J
7,8a = 4.5
Hz, J
8a,8b = 12.3 Hz,
4 H-8a), 4.14 (dd, 4 H, J
7,8b = 1.8
Hz, 4 H-8b), 3.35-3.29 (m, 4 H, 4 H-7), 1.84, 1.74, 1.72,
and 1.64 (4 s, 48 H, 16 Ac); MALDI-TOF MS: 1519.3 (M + Na),
1535.8 (M + K).
<A NAME="RD14102ST-19">19</A>
Compound 18:
mp 292-294 °C, dec. (MeOH); [α]D
20 = -4.1 (c 0.3, H2O); 1H
NMR (D2O): δ 7.65 (s, 2 H, Ar), 4.29-4.24 (m,
4 H, 4 H-3), 3.81 (dd, 4 H, J
7,8a = 1.1
Hz, J
8a,8b = 12.5
Hz, 4 H-8a), 3.63 (dd, 4 H, J
7,8b = 5.1
Hz, 4 H-8b), 3.48-3.30 (m, 16 H). Compound 19: [α]D
20 = -39.6
(c 0.6, H2O); 1H
NMR (D2O): δ 6.98 (s, 2 H, Ar), 3.75 (dd, 4
H, J
7,8a = 0.8 Hz,
J
8a,8b = 12.5 Hz,
4 H-8a), 3.54 (dd, 4 H, J
7,8b = 3.8
Hz,
4 H-8b), 3.23-3.12 (m, 12 H), 3.03-2.98
(m, 8 H), 2.71-2.56 (m, 8 H), 1.95-1.83 (m, 4
H), 1.60-1.46 (m, 4 H).